Literature DB >> 23708322

The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.

Sandra Colazingari1, Mariangela Treglia, Robert Najjar, Arturo Bevilacqua.   

Abstract

PURPOSE: The present study aims to investigate the effects of the combined therapy myo-inositol (MI) plus D-chiro-inositol (DCI) or D-chiro-inositol treatment in oocyte quality.
METHODS: Polycystic ovary syndrome (PCOS) women undergoing IVF-ET were treated with myo-inositol combined with D-chiro-inositol in the physiological ratio (1.1 g myo-inositol plus 27.6 mg of D-chiro-inositol; INOFOLIC combi Lo.Li.pharma) or D-chiro-inositol alone (500 mg; Interquim, s.a., Barcelona, Spain) to evaluate the umber of morphological mature oocytes, total International Units (IU) of recombinant FSH administered and the number of grade 1 embryos.
RESULTS: The data clearly showed that only the combined therapy was able to improve oocyte and embryo quality, as well as pregnancy rates, in PCOS women undergoing IVF-ET.
CONCLUSION: The present paper further supports the hypothesis that MI plays a crucial role in the ovary in PCOS women. In particular, due to the physiological role played by MI and DCI, the combined therapy should represent a better choice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23708322     DOI: 10.1007/s00404-013-2855-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  25 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

Review 2.  Antioxidants for female subfertility.

Authors:  Marian G Showell; Rebecca Mackenzie-Proctor; Vanessa Jordan; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2017-07-28

3.  Improvement of mouse embryo quality by myo-inositol supplementation of IVF media.

Authors:  Sandra Colazingari; Maria Teresa Fiorenza; Gianfranco Carlomagno; Robert Najjar; Arturo Bevilacqua
Journal:  J Assist Reprod Genet       Date:  2014-02-14       Impact factor: 3.412

4.  Inositol for subfertile women with polycystic ovary syndrome.

Authors:  Marian G Showell; Rebecca Mackenzie-Proctor; Vanessa Jordan; Ruth Hodgson; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2018-12-20

Review 5.  Inositol Treatment and ART Outcomes in Women with PCOS.

Authors:  Deepika Garg; Reshef Tal
Journal:  Int J Endocrinol       Date:  2016-10-04       Impact factor: 3.257

6.  Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study.

Authors:  Guluzar Arzu Turan; Fatma Eskicioglu; Oya Nermin Sivrikoz; Hakan Cengiz; Saban Adakan; Esra Bahar Gur; Sumeyra Tatar; Nur Sahin; Osman Yilmaz
Journal:  Arch Gynecol Obstet       Date:  2015-05-20       Impact factor: 2.344

Review 7.  Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials.

Authors:  Vittorio Unfer; John E Nestler; Zdravko A Kamenov; Nikos Prapas; Fabio Facchinetti
Journal:  Int J Endocrinol       Date:  2016-10-23       Impact factor: 3.257

Review 8.  Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review.

Authors:  Matteo Iervolino; Elisa Lepore; Gianpiero Forte; Antonio Simone Laganà; Giovanni Buzzaccarini; Vittorio Unfer
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

9.  High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries.

Authors:  Arturo Bevilacqua; Jessica Dragotto; Micaela Lucarelli; Giovanna Di Emidio; Giovanni Monastra; Carla Tatone
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 10.  How to Achieve High-Quality Oocytes? The Key Role of Myo-Inositol and Melatonin.

Authors:  Salvatore Giovanni Vitale; Paola Rossetti; Francesco Corrado; Agnese Maria Chiara Rapisarda; Sandro La Vignera; Rosita Angela Condorelli; Gaetano Valenti; Fabrizio Sapia; Antonio Simone Laganà; Massimo Buscema
Journal:  Int J Endocrinol       Date:  2016-08-29       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.